Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
Terns Pharmaceuticals (NASDAQ: TERN), a clinical-stage biopharmaceutical company focused on developing small-molecule treatments for oncology and obesity, has announced its participation in two major investor conferences in June 2025:
- The Jefferies Global Healthcare Conference on June 5, 2025, at 11:05 a.m. ET in New York City
- The Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025, at 4:00 p.m. ET in Miami
Both presentations will be in a fireside chat format and will be available via webcast on the company's investor relations website, with replays accessible for at least 30 days after the events.
Terns Pharmaceuticals (NASDAQ: TERN), un'azienda biofarmaceutica in fase clinica specializzata nello sviluppo di trattamenti a piccola molecola per oncologia e obesità, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025:
- La Jefferies Global Healthcare Conference il 5 giugno 2025 alle 11:05 ET a New York City
- La Goldman Sachs 46th Annual Global Healthcare Conference il 9 giugno 2025 alle 16:00 ET a Miami
Entrambe le presentazioni si svolgeranno in formato fireside chat e saranno disponibili in webcast sul sito web delle relazioni con gli investitori dell'azienda, con repliche accessibili per almeno 30 giorni dopo gli eventi.
Terns Pharmaceuticals (NASDAQ: TERN), una empresa biofarmacéutica en etapa clínica enfocada en desarrollar tratamientos con pequeñas moléculas para oncología y obesidad, ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025:
- La Jefferies Global Healthcare Conference el 5 de junio de 2025 a las 11:05 a.m. ET en la ciudad de Nueva York
- La Goldman Sachs 46th Annual Global Healthcare Conference el 9 de junio de 2025 a las 4:00 p.m. ET en Miami
Ambas presentaciones serán en formato fireside chat y estarán disponibles vía webcast en el sitio web de relaciones con inversores de la compañía, con repeticiones accesibles durante al menos 30 días después de los eventos.
Terns Pharmaceuticals (NASDAQ: TERN)는 종양학 및 비만 치료용 소분자 약물 개발에 주력하는 임상 단계의 바이오제약 회사로, 2025년 6월 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다:
- 2025년 6월 5일 오전 11시 05분(동부시간), 뉴욕시에서 열리는 Jefferies Global Healthcare Conference
- 2025년 6월 9일 오후 4시(동부시간), 마이애미에서 열리는 Goldman Sachs 46th Annual Global Healthcare Conference
두 발표 모두 파이어사이드 채팅 형식으로 진행되며, 회사 투자자 관계 웹사이트를 통해 웹캐스트로 제공되고, 행사 후 최소 30일간 재시청이 가능합니다.
Terns Pharmaceuticals (NASDAQ: TERN), une société biopharmaceutique en phase clinique spécialisée dans le développement de traitements à petites molécules pour l'oncologie et l'obésité, a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025 :
- La Jefferies Global Healthcare Conference le 5 juin 2025 à 11h05 ET à New York
- La Goldman Sachs 46th Annual Global Healthcare Conference le 9 juin 2025 à 16h00 ET à Miami
Les deux présentations se dérouleront sous forme de discussion informelle (fireside chat) et seront disponibles en webcast sur le site des relations investisseurs de la société, avec des rediffusions accessibles pendant au moins 30 jours après les événements.
Terns Pharmaceuticals (NASDAQ: TERN), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung von kleinmolekularen Therapien für Onkologie und Adipositas spezialisiert hat, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Juni 2025 angekündigt:
- Die Jefferies Global Healthcare Conference am 5. Juni 2025 um 11:05 Uhr ET in New York City
- Die Goldman Sachs 46th Annual Global Healthcare Conference am 9. Juni 2025 um 16:00 Uhr ET in Miami
Beide Präsentationen finden im Fireside-Chat-Format statt und werden per Webcast auf der Investor-Relations-Website des Unternehmens verfügbar sein, mit Wiederholungen, die mindestens 30 Tage nach den Veranstaltungen abrufbar sind.
- None.
- None.
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in the following upcoming investor conferences in June.
Jefferies Global Healthcare Conference
Format: Fireside Chat
Date and Time: Thursday, June 5, 2025 at 11:05 a.m ET
Location: New York City
Goldman Sachs 46th Annual Global Healthcare Conference
Format: Fireside Chat
Date and Time: Monday, June 9, 2025 at 4:00 p.m. ET
Location: Miami
Live webcasts of the fireside chats will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcasts will be archived on Terns’ website for at least 30 days following the presentations.
About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist, and a preclinical GIPR modulator discovery effort, prioritizing a GIPR antagonist nomination candidate. For more information, please visit: www.ternspharma.com.
Contacts for Terns
Investors
Kaytee Bock Zafereo
investors@ternspharma.com
Media
Jenna Urban
CG Life
media@ternspharma.com
FAQ
When is Terns Pharmaceuticals (TERN) presenting at the Jefferies Healthcare Conference 2025?
What time is TERN's presentation at the Goldman Sachs Healthcare Conference 2025?
Where can I watch Terns Pharmaceuticals' (TERN) June 2025 investor conference presentations?
What therapeutic areas does Terns Pharmaceuticals (TERN) focus on?
